Published in Healthcare Mergers, Acquisitions and Ventures Week, June 16th, 2007
Following this approval, A.P. Pharma is implementing an immediate 1-for-4 reverse stock split, which will be effective upon the beginning of trading on May 24, 2007. Prior to the split, the Company had approximately 25.4 million common shares outstanding.
Keywords: A.P. Pharma, Pharmaceuticals.
This article was prepared by Healthcare Mergers,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.